| Tag | Content |
|---|
EnhancerAtlas ID | HS098-28240 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr19:47465160-47467200 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr19:47465224-47465242 | GAAAGAGAGAAAGGAAGG | + | 6.08 | | EWSR1-FLI1 | MA0149.1 | chr19:47465228-47465246 | GAGAGAAAGGAAGGAAGG | + | 7.26 | | EWSR1-FLI1 | MA0149.1 | chr19:47465236-47465254 | GGAAGGAAGGAAGGGAAG | + | 8.57 | | EWSR1-FLI1 | MA0149.1 | chr19:47465232-47465250 | GAAAGGAAGGAAGGAAGG | + | 9.6 | | Foxo1 | MA0480.1 | chr19:47465362-47465373 | TGCTGTTTACA | + | 6.14 | | GATA2 | MA0036.3 | chr19:47465495-47465506 | AAAGATAAGAA | - | 6.62 | | IRF1 | MA0050.2 | chr19:47465213-47465234 | AGAGAGAAAGAGAAAGAGAGA | - | 6.65 | | Mecom | MA0029.1 | chr19:47466931-47466945 | CTTTATCTTGTCTC | - | 6.11 | | ZNF263 | MA0528.1 | chr19:47465237-47465258 | GAAGGAAGGAAGGGAAGGGAA | + | 6.6 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_04286 | chr19:47466260-47467040 | Brain_Anterior_Caudate | | SE_05055 | chr19:47465134-47467036 | Brain_Cingulate_Gyrus | | SE_44180 | chr19:47465091-47468421 | NHDF-Ad | | SE_45556 | chr19:47460520-47468451 | Osteoblasts | | SE_55914 | chr19:47464359-47468281 | u87 | | SE_67936 | chr19:47464359-47468281 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr19 | 47466294 | 47467022 | | chr19 | 47465274 | 47465846 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I046961 | chr19 | 47465076 | 47468121 |
|
Enhancer Sequence | TGTGTGACAG AGTGAGATCC TGCCTCAAAA AAGAGAGAGA GAAAGAAAGA AAAAGAGAGA 60
AAGAGAAAGA GAGAAAGGAA GGAAGGAAGG GAAGGGAAGG AAAGGATTGG GATAGTGGAT 120
ATCCTTGGGG AGGGAGTAGA GGCTGGTAGA GGGCACAAAA GGCTTCTGGA ATGCTGGGAT 180
GTTTTGTGTC TTGATCTGTG GGTGCTGTTT ACACAAGTGT GGTCATTGTG TGAAAATCCA 240
TCACCGTACA CTTCTCTGTA AACTTCTGAA TGTGTATTAT CTTTCAATAA GAGTTTGTTT 300
TTTAAAAAAG CCTCTAGTCC CAACTCTTCC ATTTTAAAGA TAAGAACCCA GGAGTTGAAG 360
AGATTCCCCA CTGTCTTGCC ATATGAGCAG CTCAGGGTTT CTGAGAGCCT GTGCAAGAAG 420
CCAGAGCCCT GGCCTGCCTT GCCAAGACTG GCTAGTGATG TTGTTGGCAC TTGGAAAGGC 480
CGTGAATGTG TGACAATGTC TCTCACCTTG AGGCCCCTGA AGAATAATGG AGAGTCTCAG 540
AGCCAGCTCA TGTGTCAAAT GGAATTTCTG GTTTTATAGC TTATGCTCTT GTGTTTAGGG 600
CAGAAATTCT AGCACAAGGC CTCACACCCA GGCAGTAGAC AAGGGTGGGG AAGTTTCTGA 660
TGGAGAAAAG TTCGGTTCTC TGTTACTCTG GCCAACCTCT CATTCTTTTG TTTTTGTTTT 720
TGAAATGGAG TCTCGCTTTG TCGCCCAGGC TGGAGTGCAG TGGTGCGATC TTGGCTCATT 780
GCAACCTCCA CCTCCCAGGT TCCAGTGATT CTCCTGCCTC CTGCCTCAGC CTCCCACGTA 840
GATGGGATTA CAGGCATGCA CCACCACACC CAGCTAATTT TTGTATTTTT AGTAGAGATG 900
AGGTTTTACC ATGTTGGCCA GGCTGGTCTC GAACTCCTGA CCTCAGGTGA TCCGCCCGCA 960
CTTGGCCAAA GTGCTGGGAT CGCAGGCATG AGCCACTGCG CCCGGCCTCA ACCTCTCATT 1020
CTTAGTCCTT TTTCTCACTG CATCCTCATC CTTCCCGTTT TGCTGCTGCT TCCTACTCCT 1080
TTTCAGGCTA GCCTATTTCA GAAAATTTTA TCTTTTTTAG TAAAATTATT TGCTCAGAAT 1140
AAAAATAAAG CAGATTTCTG TTTCATTCTT CCTGGGCCTG CTTTGGGAGG GTGGTGAGTG 1200
GTGAACTCCA AGGAATTGTT TGCATGGTGT GCTACCCTGA TGGGAGATTC TCAGCGTCCA 1260
GGATTCCTTT ACTTTTCTGT GGGGGTTCTA TCTGGAAACC TTATGTGACT CAGGGCATAG 1320
TATGATTTTG AGCACTTCCT GTGGTCAAAA ACTGTTGTCT TTGATTGGAA ATTATGCTGT 1380
GTTCTGAGTG CTTGCTGGCA CGCACACACT GTTGACTGCT TGTTCTGGTA GCACATCTGC 1440
GTGGGGTGCC TTAAAAGTGG GCACTCTCTC AGCAGAAAAT TCCCATGTGG GACCTCAGTT 1500
CAAGCCCCTC CTCACTTTCA TCACTTTCTT CTCTTTTGCT TCCCTTCCTC TGTGCCTTCA 1560
CTCCTCCACA CTGGCCTCAG CAAATCCCAT CTATTTTCCA AGCCCCATCT GAAAGCGTGC 1620
CTCTTCTCTG ATGACCATCC TTGTTGGAGC TGACTTTGCC GTCCCTCCTG TGGACATCCA 1680
TGCCAGTTGT CTGTGTCATC TGTTTAGCAG TCATCTGGTC CTAACTTTTA GCTTATCTTT 1740
TATTATATCT AAGTGTGATC TAACTTTTCA CCTTTATCTT GTCTCCCTGT CACCTCGAAA 1800
GAGGACACGA CAGTGCTGTT AATTTTTCTA TCTCCCATGG GACTTAATCG GTGTCCTCCA 1860
CGTAGTATGC TTTAATAATG GTTTATTGCT GTGATACTGC TTCACAAATG CCAGCAGATG 1920
CCATGCTGTA TCATCAGAGA TGAGATTATT TTATTTATTT ATTTTTAATT TTTTTATTTT 1980
TTGAGATGGA ATCTTGCTCT GTCACCCAGG CTGGAGTGCA GTGGCGCAAT CTCGGCTCAC 2040
|
